Identifying Risk Factors for Racial Disparities in Diabetes Outcomes: The Translating Research into Action for Diabetes Study

Background: Versus whites, blacks with diabetes have poorer control of hemoglobin A1c (HbA1c), higher systolic blood pressure (SBP), and higher low-density lipoprotein (LDL) cholesterol as well as higher rates of morbidity and microvascular complications. Objective: To examine whether several mutabl...

Full description

Saved in:
Bibliographic Details
Published in:Medical care 2009-06, Vol.47 (6), p.700-706
Main Authors: Duru, O. Kenrik, Gerzoff, Robert B., Selby, Joseph V., Brown, Arleen F., Ackermann, Ronald T., Karter, Andrew J., Ross, Sonja, Steers, W. Neil, Herman, William H., Waitzfelder, Beth, Mangione, Carol M.
Format: Article
Language:English
Subjects:
Black or African American
Black people
Blood Pressure
Brief Reports
Case-Control Studies
Cholesterol, LDL - blood
Cholesterols
Depression - complications
Depressive disorders
Diabetes
Diabetes complications
Diabetes Mellitus - ethnology
Diabetes Mellitus - psychology
Diabetes Mellitus - therapy
Female
Glycated Hemoglobin - analysis
Health outcomes
Healthcare Disparities
Hemoglobin
Humans
Low density lipoprotein
Male
Managed care
Medication Adherence
Medications
Mental health outcomes
Middle Aged
Multivariate Analysis
Predisposing factors
Professional-Patient Relations
Racial differences
Risk Factors
Self Efficacy
Type 2 diabetes mellitus
White people
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Versus whites, blacks with diabetes have poorer control of hemoglobin A1c (HbA1c), higher systolic blood pressure (SBP), and higher low-density lipoprotein (LDL) cholesterol as well as higher rates of morbidity and microvascular complications. Objective: To examine whether several mutable risk factors were more strongly associated with poor control of multiple intermediate outcomes among blacks with diabetes than among similar whites. Design: Case-control study. Subjects: A total of 764 blacks and whites with diabetes receiving care within 8 managed care health plans. Measures: Cases were patients with poor control of at least 2 of 3 intermediate outcomes (HbA1c ≥8.0%, SBP ≥140 mmHg, LDL cholesterol ≥130 mg/dL) and controls were patients with good control of all 3 (HbA1c
ISSN:0025-7079
1537-1948
DOI:10.1097/MLR.0b013e318192609d